Regulation of Immunotherapy Resistance in CDKN2A-low Melanoma by Adam Smartt | Sep 26, 2022 | Career Development Award
Targeting Melanoma-Intrinsic STING signaling to Restore Antitumor Immunity by Adam Smartt | Sep 26, 2022 | Career Development Award
Exploiting Metabolic Vulnerabilities of Macrophages for Melanoma Treatment by Adam Smartt | Sep 26, 2022 | Career Development Award
Therapeutic Combinations against Melanoma Brain Metastases by Adam Smartt | Sep 26, 2022 | Career Development Award
Pilot Trial of Tumor Infiltrating Lymphocytes for Melanoma Brain Metastasis by Adam Smartt | Sep 26, 2022 | Career Development Award
Melanoma Risks and Risk Prediction in Patients with Actinic Keratosis by Adam Smartt | Dec 31, 2021 | Career Development Award, Featured
Recent Comments